Dr. Roger McIntyre

Dr. Roger McIntyre is currently a professor of psychiatry and pharmacology at the University of Toronto and head of the Mood Disorders Psychopharmacology Unit at the University Health Network in Toronto. He holds numerous other positions, including Executive Director of the Brain and Cognition Discovery Foundation in Toronto; Director and Co-Chair of the Scientific Advisory Board of the Depression and Bipolar Support Alliance in Chicago; Professor and Nanshan Scholar at Guangzhou Medical University in China; Adjunct Professor at the College of Medicine at Korea University; Clinical Professor at the State University of New York (SUNY) Upstate Medical University in Syracuse; Clinical Professor in the Department of Psychiatry and Neurosciences at the University of California, Riverside, School of Medicine; and President and Chief Executive Officer of Champignon.

Dr. McIntyre is involved in multiple research endeavours that primarily aim to characterize the association between mood disorders, notably cognitive function and medical comorbidity. His works broadly aim to characterize the underlying causes of cognitive impairment in individuals with mood disorders and their impact on workplace functioning. This body of work has provided a platform for identifying novel molecular targets to treat and prevent mood disorders and accompanying cognitive impairment.

Dr. McIntyre is extensively involved in medical education. He is a highly sought-after speaker at both national and international meetings. He has received several teaching awards from the University of Toronto Department of Psychiatry and has been a recipient of the joint Canadian Psychiatric Association/Council of Psychiatric Continuing Education Award for the "Most Outstanding Continuing Education Activity in Psychiatry in Canada."

Dr. McIntyre is the lead author for the Florida Best Practice Psychotherapeutic Medication Guidelines for Adults with Major Depressive Disorder and Bipolar Disorder. He is also a contributor to the Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the treatment of depressive disorders and bipolar disorders. He has published more than 600 articles and manuscripts and has edited and/or co-edited several textbooks on mood disorders. Dr. McIntyre has been named by Clarivate Analytics from 2014 to 2019 as one of the "World's Most Influential Scientific Minds," a distinction given to individuals who have published the largest number of articles that rank among those most frequently cited by researchers globally in 21 broad fields of science and social science during the previous decade.

Dr. McIntyre holds an M.D. from Dalhousie University. He received his psychiatry residency training and fellowship in psychiatric pharmacology at the University of Toronto. He is a Fellow of The Royal College of Physicians of Canada.

Tel: (416) 603-5279
Email: Roger.McIntyre@uhn.ca